BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jameson A, Fylan B, Bristow GC, Sagoo GS, Dalton C, Cardno A, Sohal J, McLean SL. What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings? Front Genet 2021;12:740216. [PMID: 34630531 DOI: 10.3389/fgene.2021.740216] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Jacobson PA, Johnson ANK, Gregornik DB, Johnson SG, McCarty CA, Bishop JR. Public Attitudes toward Pharmacogenomic Testing and Establishing a Statewide Pharmacogenomics Database in the State of Minnesota. J Pers Med 2022;12:1615. [PMID: 36294754 DOI: 10.3390/jpm12101615] [Reference Citation Analysis]
2 Al-mahayri ZN, Khasawneh LQ, Alqasrawi MN, Altoum SM, Jamil G, Badawi S, Hamza D, George L, Alzaabi A, Ouda H, Al-maskari F, Alkaabi J, Patrinos GP, Ali BR. Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates. Hum Genomics 2022;16. [DOI: 10.1186/s40246-022-00417-9] [Reference Citation Analysis]
3 Mcdermott JH, Wright S, Sharma V, Newman WG, Payne K, Wilson P. Characterizing pharmacogenetic programs using the consolidated framework for implementation research: A structured scoping review. Front Med 2022;9. [DOI: 10.3389/fmed.2022.945352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Fabbri C. Pharmacogenetics in psychiatry: some key clinical considerations. Minerva Psychiatry 2022;63. [DOI: 10.23736/s2724-6612.22.02363-6] [Reference Citation Analysis]
5 Maruf AA, Bousman CA. Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic. PCN Reports 2022;1. [DOI: 10.1002/pcn5.26] [Reference Citation Analysis]
6 Salloum RG, Bishop JR, Elchynski AL, Smith DM, Rowe E, Blake KV, Limdi NA, Aquilante CL, Bates J, Beitelshees AL, Cipriani A, Duong BQ, Empey PE, Formea CM, Hicks JK, Mroz P, Oslin D, Pasternak AL, Petry N, Ramsey LB, Schlichte A, Swain SM, Ward KM, Wiisanen K, Skaar TC, Van Driest SL, Cavallari LH, Tuteja S. Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy. Implement Sci Commun 2022;3:52. [PMID: 35568931 DOI: 10.1186/s43058-022-00300-7] [Reference Citation Analysis]
7 Youssef E, Thornley T, Guchelaar H, Wright DJ. Pharmacogenetics: optimising prescribing in primary care. Prescriber 2022;33:10-13. [DOI: 10.1002/psb.1982] [Reference Citation Analysis]
8 Baune B. Clinical use of pharmacogenomics in Psychiatry: The future has not yet arrived. European Neuropsychopharmacology 2022;58:4-6. [DOI: 10.1016/j.euroneuro.2022.01.006] [Reference Citation Analysis]
9 Larrieu-Jimenez P, Salani D. When Moods and Behaviors Do Not Add Up: The Many Masks of Alcohol Use Disorder. J Addict Nurs 2022;33:121-4. [PMID: 35640217 DOI: 10.1097/JAN.0000000000000462] [Reference Citation Analysis]
10 Massmann A, Schultz A, Van Heukelom J. Integration of clinical decision support infrastructure and translating into real-world applications. Clinical Decision Support for Pharmacogenomic Precision Medicine 2022. [DOI: 10.1016/b978-0-12-824453-1.00007-5] [Reference Citation Analysis]
11 Boyce RD, Camacho J, Liang W, Wiisanen K, Devine B. Overview of effective pharmacogenomic clinical decision support. Clinical Decision Support for Pharmacogenomic Precision Medicine 2022. [DOI: 10.1016/b978-0-12-824453-1.00010-5] [Reference Citation Analysis]